Basic science research provides the foundation for medical advances and breakthroughs. The innovative research conducted by University of Maryland School of Medicine faculty is translating to improved patient care. For example, genetic testing helps doctors determine which medication a patient should receive after a stenting procedure to prevent blood clots, based on research led by Dr. Alan Shuldiner showing an association between a gene variation and reduced benefit from clopidogrel. Hundreds of faculty members conduct research funded by NIH and others to create new treatments, such as Dr. Christopher Plowe's work to prevent drug-resistant malaria. Pharmacogenomics research led by Dr. Shuldiner is already being applied in clinical practice to guide treatment for heart patients.
Dr. Abdul Rao, Chief Executive Officer and Chief Research Officer, The Institute of Women's health, North America implemented a strategic plan to create an enterprise- wide paper less environment in all its campuses and also at the same time made it available to a wide array of patients and their caregivers in a safe and user friendly environment.
Abdul Rao Insights On H1N1 Vaccination DriveAbdul Rao
Dr. Abdul Rao, the Chief Executive Officer and Chief Research Officer of The Institute of Women’s Health of North America. The institute collaborated with FloridaSHOTS under his Directorship to initiate a 2009 H1N1 Influence virus vaccination program in all six affiliated campuses in Florida.
2015 06-02 Steering group 'Personalized Medicine: eligible or not'Alain van Gool
Update for the steering group of the project "Personalized Medcine: eligble or not?", aiming to define whether and how to implement pharmacogenetic screening by first line care practitioners.
Dr. Abdul Rao, Chief Executive Officer and Chief Research Officer, The Institute of Women's health, North America implemented a strategic plan to create an enterprise- wide paper less environment in all its campuses and also at the same time made it available to a wide array of patients and their caregivers in a safe and user friendly environment.
Abdul Rao Insights On H1N1 Vaccination DriveAbdul Rao
Dr. Abdul Rao, the Chief Executive Officer and Chief Research Officer of The Institute of Women’s Health of North America. The institute collaborated with FloridaSHOTS under his Directorship to initiate a 2009 H1N1 Influence virus vaccination program in all six affiliated campuses in Florida.
2015 06-02 Steering group 'Personalized Medicine: eligible or not'Alain van Gool
Update for the steering group of the project "Personalized Medcine: eligble or not?", aiming to define whether and how to implement pharmacogenetic screening by first line care practitioners.
A/Professor Shane Grey, Head, Transplantation & Immunology, Garvan Institute of Medical Research. http://www.garvan.org.au/news-events/leaders-in-science-and-society
2015 09-14 Precision Medicine 2015, London, Alain van GoolAlain van Gool
Outline of my view hoe personalized health(care) is more than just targeted medicines, also including personal motivation and actions towards disease prevention. It also outlines 4 key factors that should be in order for optimal personalized health(care): 1. start with patients first, 2. Accelerate translation research to application, 3. Copy best practice, 4. Spread the word.
A cardiologist and researcher with decades of experience, Dr. Sanjiv M. Narayan serves as the director of the Stanford Arrhythmia Center. Formerly a professor of medicine at UC San Diego, Sanjiv Narayan, MD, PhD, has devoted the majority of his research career to the study of atrial fibrillation (AF).
Claudia presented her poster "Treating Coronary Heart Disease in Diabetic Patients: a systematic review of systematic reviews" at the CUTEHeart Poster session of CPC2016.
An Individualized Career Path in Personalized MedicineSherry-Ann Brown
www.drbrowncares.com
Walk through a physician scientist's individualized career path that combines various passions. Find your own passions and consider how to integrate them into your individualized career path, as we all forge ahead in personalized medicine.
@drbrowncares
Evaluation of comorbid autoimmune diseases among patients and family members enrolled in the Alopecia
Areata Registry, Biobank & Clinical Trials Network.
MT115 Precision Medicine: Integrating genomics to enable better patient outcomesDell EMC World
"The emergence of genomics and real-time screening is helping to transform the practice of medicine as we know it today. New technologies present improved ways to tackle health issues and what was once thought to be “untouchable” due to cost, timing or resources, is now achievable through genetic screenings and genome sequencing.
During this session, we will explore:
1. The benefits of incorporating a genomics strategy early in lifeline
2. The Precision Medicine Initiative – how does this help? Does this encourage more people to get genetic screenings?
3. What’s involved in a genetic screening
"
Vitiligo and alopecia areata are both common, T cell-driven autoimmune diseases of the skin. Recognizing
similarities and differences between these diseases will promote a more complete understanding of their
pathogenesis as well as the development of new treatments.
A/Professor Shane Grey, Head, Transplantation & Immunology, Garvan Institute of Medical Research. http://www.garvan.org.au/news-events/leaders-in-science-and-society
2015 09-14 Precision Medicine 2015, London, Alain van GoolAlain van Gool
Outline of my view hoe personalized health(care) is more than just targeted medicines, also including personal motivation and actions towards disease prevention. It also outlines 4 key factors that should be in order for optimal personalized health(care): 1. start with patients first, 2. Accelerate translation research to application, 3. Copy best practice, 4. Spread the word.
A cardiologist and researcher with decades of experience, Dr. Sanjiv M. Narayan serves as the director of the Stanford Arrhythmia Center. Formerly a professor of medicine at UC San Diego, Sanjiv Narayan, MD, PhD, has devoted the majority of his research career to the study of atrial fibrillation (AF).
Claudia presented her poster "Treating Coronary Heart Disease in Diabetic Patients: a systematic review of systematic reviews" at the CUTEHeart Poster session of CPC2016.
An Individualized Career Path in Personalized MedicineSherry-Ann Brown
www.drbrowncares.com
Walk through a physician scientist's individualized career path that combines various passions. Find your own passions and consider how to integrate them into your individualized career path, as we all forge ahead in personalized medicine.
@drbrowncares
Evaluation of comorbid autoimmune diseases among patients and family members enrolled in the Alopecia
Areata Registry, Biobank & Clinical Trials Network.
MT115 Precision Medicine: Integrating genomics to enable better patient outcomesDell EMC World
"The emergence of genomics and real-time screening is helping to transform the practice of medicine as we know it today. New technologies present improved ways to tackle health issues and what was once thought to be “untouchable” due to cost, timing or resources, is now achievable through genetic screenings and genome sequencing.
During this session, we will explore:
1. The benefits of incorporating a genomics strategy early in lifeline
2. The Precision Medicine Initiative – how does this help? Does this encourage more people to get genetic screenings?
3. What’s involved in a genetic screening
"
Vitiligo and alopecia areata are both common, T cell-driven autoimmune diseases of the skin. Recognizing
similarities and differences between these diseases will promote a more complete understanding of their
pathogenesis as well as the development of new treatments.
Competition genomic medicine presentationResearchsio
Prepared By Roman Sharkar and Mir Tasfiq Alam. Both of them are students of the B.Pharm Program in Bangladesh. They prepared this ppt file from their choice of interest which is Genomic Medicine. Hope this will handly to the others who are interested in this topic !!
Introduction to Robert F. Kennedy Jr. book available on Amazon. https://amzn.to/365aF8V
I created this PDF file of the intro to his book to give people a good idea what the book is about. I had no idea what I was getting into when I got the book. No people or person should be given as much power as Fauci, big pharma and big tech has.
Many thanks to Robert F Kennedy Jr for the time and effort he spent putting this together for the world to read.
As medical director of Empire State Pain & Neuro PC in Brentwood, New York, Dr. Samuel Theagene provides state-of-the-art pain management solutions, including spine interventions with fluoroscopy and electromyography. Outside of work, Samuel M. Theagene, MD, gives to St. Jude Children’s Research Hospital.
Immunology deals with the study of the physiological function human immune system. It is a pivotal part of Biology, and also the most daunting. According to Kanury Rao, a healthy immune system is the result of a complex interaction of internal and environmental factors. Age, diet, and availability of medical care are among them, as are socioeconomic factors including income level and type of employment.
Advances in integrative nanomedicine for improving infectious disease treatme...home
Nanomedicine is integrative, blending modern technology with natural products to reduce toxicity and support immune function. Nanomedicine using traditional agents from alternative systems of medicine can facilitate progress in integrative public health approaches to infectious diseases.
1. BUILDING BLOCKS
toAdvanceMedicine
UMMS/SOM 14
2013 Annual Report
Medical breakthroughs are built upon the foundation of basic science research. What is
known today about human health and disease stems from discoveries made in research
laboratories using animal models and human and animal cell lines or by studying genes
and microbes.
The innovative research conducted by University of Maryland School of Medicine
faculty is dramatically changing the care patients receive. At the University of Maryland
Medical Center, genetic testing helps doctors determine which medication a patient
should take after a stenting procedure in order to prevent blood clots that could lead
to heart attacks and strokes.
This advancement is based on research by Alan R. Shuldiner, MD, the John L.
Whitehurst Endowed Professor of Medicine, associate dean for personalized and
genomic medicine and co-director of the University of Maryland Clinical and
Translational Sciences Institute. In 2009, he led a study, published in the Journal of the
American Medical Association, showing that patients with a CYP2C19 gene variation
exhibited reduced clinical benefit from taking clopidogrel.
Hundreds of faculty members conduct research — with funding from the National
Institutes of Health and other sources — to create the building blocks of tomorrow’s
advances in patient care. For example, Christopher Plowe, MD, MPH, professor
of medicine, epidemiology and public health and microbiology and immunology, a
Howard Hughes Medical Institute Investigator and leader of the Malaria Group at the
Center for Vaccine Development, is working with a team to prevent the spread of
drug-resistant malaria.
DISCOVERY TRANSLATES TO BETTER CARE
Pharmacogenomics — how genes affect a person’s response to drugs — is a burgeoning area of
research, but only a few hospitals in the United States have applied it to clinical practice. Research led
by Dr. Shuldiner is already the basis of testing offered by cardiologist Mark Vesely, MD, assistant
professor of medicine, who cares for patients at UMMC and the Baltimore VA Medical Center. Richard
Zhao, PhD, professor of pathology, directs the Translational Genomics Laboratory at the School of
Medicine, where the genetic testing for patients is performed.
Battling influenza
Fighting infectious diseases is a key
area for basic science research.
Stefanie Vogel, PhD, professor
in the departments of Microbiology
and Immunology and Medicine, is
part of the team that found that an
experimental drug can treat influ-
enza and prevent virus-induced lung
injury and death in animal models,
even when administered days after
initial infection.
Stefanie Vogel, PhD
Richard Zhao, PhD, Alan Shuldiner, MD, and Mark Vesely, MD